A review links sleep-wake disruption in ALS and other neurodegenerative diseases to altered brain activity
Original source
Sleep-wake control with age and neurodegenerative diseases. (opens in a new tab)Compass summarised this from the study's abstract.
Study details
- Study type
- Review
A review examines how ageing and neurodegenerative diseases affect sleep-wake control. It identifies increased neuronal excitability as a possible shared mechanism behind sleep disruption across several conditions, including amyotrophic lateral sclerosis (ALS). The review discusses these mechanisms as a basis for future research into treatments, not as a current treatment change.
Why this matters
Sleep problems may be relevant to people living with ALS, but this review does not test a treatment or establish that changing neuronal excitability improves sleep or ALS outcomes. Its findings may help guide future research into sleep-related mechanisms and therapies.
Limitations and context
This is a review article, not a new clinical trial or treatment study. The source summary does not provide ALS-specific participant numbers, treatment results, or evidence that the proposed mechanism causes sleep problems in ALS. Any future strategy would still need to be tested in people with ALS.